EAM Global Investors’s AtriCure ATRC Stock Holding History

EAM Global Investors’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-38,088	Closed	-$1.71M	–	135
2020 Q2	$1.71M	Sell	38,088 -13,283	-26%	-$578K	0.77%	56
2020 Q1	$1.73M	Buy	+51,371	New	+$1.85M	1.01%	35
2019 Q1	–	Sell	-53,553	Closed	-$1.64M	–	130
2018 Q4	$1.64M	Hold	53,553	–	–	0.9%	32
2018 Q3	$1.88M	Hold	53,553	–	–	0.76%	27
2018 Q2	$1.45M	Buy	+53,553	New	+$1.26M	0.71%	44

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM Global Investors's ATRC Position: Q3 2020 in Review

EAM Global Investors sold out of AtriCure (ATRC) in Q3 2020, closing a stake of 38,088 shares — an estimated $1.71M sold.

EAM Global Investors first reported a position in ATRC in Q2 2018 and held it in 5 quarters. The position peaked at $1.88M in Q3 2018. 183 funds tracked by Wall St. Rank hold ATRC as of Q3 2020.

EAM Global Investors reported no remaining AtriCure position as of Q3 2020 after selling out during the quarter.
EAM Global Investors sold 38,088 AtriCure shares in Q3 2020, an estimated $1.71M.
EAM Global Investors first reported a position in AtriCure in Q2 2018 and held it in 5 quarters.
EAM Global Investors's AtriCure position peaked at $1.88M in Q3 2018.
183 funds tracked by Wall St. Rank held AtriCure as of Q3 2020.

Based on EAM Global Investors's 13F filing for Q3 2020, filed 13 Nov 2020.